MAPT and Alzheimer disease: Tau is closely linked to hypometabolism and clinical symptoms in AD (Ossenkoppele et al., 2015), and previous studies have shown greater burden of both amyloid and tau pathology in early-onset AD (Bigio et al., 2002; Marshall et al., 2007).